n

Dr. Galvin and his recently recruited and talented research team at the Comprehensive Center for Brain Health (CCBH) work has focused on applying a precision medicine-like, personalized approach to brain health and the prevention of cognitive decline. He has successfully obtained four new NIH funded research projects this year. His team in total has 28 grants (NIH, Alzheimer's Association, American Academy of Neurology/McKnight, and others) currently totaling $155 Million. To accomplish the objective of these projects, Dr. Galvin and his team have established 56 unique research collaborations with academia, industry and community partners as illustrated in the model below that used Social Network Analysis. This model illustrates not only the density and complexity of their research collaborations, but also defines two distinct networks, one focusing on brain health and dementia prevention and Alzheimer’s Disease (AD), and another focusing on Lewy body dementia (LBD).

We highlight one of Dr. Galvin’s major projects, a brain health platform that is shown to correctly segregate healthy controls from MCI and ADRD in a time and cost-efficient fashion. He developed a brain health platform that combines resilience, vulnerability and performance to assess brain health and the risk of Alzheimer’s disease and related disorders (AD/ADRD). He uses a combination of measures that take approximately 15 minutes to evaluate an individual and therefore use precision aging techniques for developing personalized strategies. He has a patent pending for his brain health platform. His overall objective involves researching the brain and cognitive aging and building a better brain through the aging process.